A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer

被引：0
|
作者：
Manabu Shiozawa
Makoto Akaike
Nobuhiro Sugano
Kazuhito Tsuchida
Naoto Yamamoto
Soichiro Morinaga
机构：
[1] Kanagawa Cancer Center,Department of Gastrointestinal Sugery
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
S-1; Irinotecan; IRIS; Advanced colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：987 / 992
页数：5
相关论文
共 50 条
  • [1] A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer
    Shiozawa, Manabu
    Akaike, Makoto
    Sugano, Nobuhiro
    Tsuchida, Kazuhito
    Yamamoto, Naoto
    Morinaga, Soichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 987 - 992
  • [2] Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer
    Goto, A.
    Yamada, Y.
    Yasui, H.
    Kato, K.
    Hamaguchi, T.
    Muro, K.
    Shimada, Y.
    Shirao, K.
    ANNALS OF ONCOLOGY, 2006, 17 (06) : 968 - 973
  • [3] Phase II study of S-1 in combination with irinotecan in patients with advanced colorectal cancer (CRC)
    Komatsu, Y
    Yuuki, S
    Amano, T
    Machida, N
    Ozasa, M
    Kato, T
    Furukawa, S
    Akita, H
    Asaka, M
    Sakata, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 297S - 297S
  • [4] A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer
    Shiozawa, Manabu
    Sugano, Nobuhiro
    Tsuchida, Kazuhito
    Morinaga, Soichiro
    Akaike, Makoto
    Sugimasa, Yukio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (03) : 365 - 370
  • [5] A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer
    Manabu Shiozawa
    Nobuhiro Sugano
    Kazuhito Tsuchida
    Soichiro Morinaga
    Makoto Akaike
    Yukio Sugimasa
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 365 - 370
  • [6] Phase II multi center study of combination therapy with irinotecan and S-1 for metastatic colorectal cancer
    Komatsu, Y.
    Yuki, S.
    Kato, K.
    Kato, S.
    Nakamura, M.
    Tateyarna, M.
    Kudo, M.
    Akita, H.
    Sakata, Y.
    Asaka, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 199 - 199
  • [7] Phase II study of combination with irinotecan and S-1(IRIS) for inoperable recurrent advanced colorectal cancer(HGCSG0302). Final analysis
    Yuki, S.
    Komatsu, Y.
    Iwanaga, I.
    Fukushima, H.
    Kudo, M.
    Tateyama, M.
    Meguro, T.
    Watanabe, M.
    Asaka, M.
    Sakata, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Phase II study of combination with irinotecan and S-1 (IRIS) for inoperable recurrent advanced colorectal cancer (HGCSG0302). Safety analysis
    Yuki, S.
    Komatsu, Y.
    Machida, N.
    Ozasa, M.
    Nishi, K.
    Miyagishima, T.
    Kato, T.
    Nakamura, M.
    Asaka, M.
    Sakata, Y.
    EJC SUPPLEMENTS, 2007, 5 (04): : 252 - 252
  • [9] Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer
    Komatsu, Yoshito
    Yuki, Satoshi
    Sogabe, Susumu
    Fukushima, Hiraku
    Nakatsumi, Hiroshi
    Kobayashi, Yoshimitsu
    Iwanaga, Ichiro
    Nakamura, Michio
    Hatanaka, Kazuteru
    Miyagishima, Takuto
    Kudo, Mineo
    Munakata, Masaki
    Meguro, Takashi
    Tateyama, Miki
    Sakata, Yuh
    ACTA ONCOLOGICA, 2012, 51 (07) : 867 - 872
  • [10] Phase I/II study of sequential combination with irinotecan and S-1 in patients with metastatic colorectal cancer
    Yoshioka, T.
    Kato, S.
    Gamoh, M.
    Suzuki, T.
    Shibata, H.
    Shimodaira, H.
    Otsuka, K.
    Kakudo, Y.
    Takahashi, S.
    Ishioka, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345